Literature DB >> 2352794

Comparison of soft tissue effects of conventional ionic, low osmolar ionic and nonionic iodine containing contrast material in experimental animals.

W H McAlister1, J M Kissane.   

Abstract

Conventional, low osmolar, and non-ionic iodine containing contrast media and saline controls were placed in the paws, muscles, and subcutaneous tissues of Sprague-Dawley rat thighs. The paw injections were observed and photographed, while the thighs were examined histologically. Results showed that although the low osmolar and non-ionic agents did produce inflammatory reactions and focal necrosis in the soft tissues, they were much better tolerated than were the conventional ionic agents. A non-ionic or low osmolar ionic contrast agent should be strongly considered when a possibility for extravasation exists.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2352794     DOI: 10.1007/bf02012965

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  27 in total

1.  Skin necrosis from extravasation of intravenous fluids in children.

Authors:  A S Brown; D J Hoelzer; S A Piercy
Journal:  Plast Reconstr Surg       Date:  1979-08       Impact factor: 4.730

2.  The histologic effects of some iodine-containing contrast media on the rat peritoneal cavity.

Authors:  W H McAlister; G D Shackleford; J Kissane
Journal:  Radiology       Date:  1972-12       Impact factor: 11.105

3.  Gangrene following peripheral phlebography of the legs.

Authors:  M L Thomas
Journal:  Br J Radiol       Date:  1970-08       Impact factor: 3.039

4.  Severe extravasation injury: an avoidable iatrogenic disaster?

Authors:  D A Burd; G Santis; T M Milward
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

5.  Changes in vascular permeability after local application of roentgen contrast media in the hamster cheek pouch.

Authors:  S E Sörensen
Journal:  Acta Radiol Diagn (Stockh)       Date:  1971-05

6.  The histologic effects of four commonly used media for excretory urography and an attempt to modify the responses.

Authors:  W H McAlister; K Palmer
Journal:  Radiology       Date:  1971-06       Impact factor: 11.105

Review 7.  Intravascular contrast media: adverse reactions.

Authors:  R H Cohan; N R Dunnick
Journal:  AJR Am J Roentgenol       Date:  1987-10       Impact factor: 3.959

8.  Tissue necrosis following extravasation of contrast material.

Authors:  G Ayre-Smith
Journal:  J Can Assoc Radiol       Date:  1982-06

9.  Experimental model of doxorubicin extravasation in the mouse.

Authors:  R T Dorr; D S Alberts; H S Chen
Journal:  J Pharmacol Methods       Date:  1980-11

10.  Extravasation: a hazard of intravenous therapy.

Authors:  M E MacCara
Journal:  Drug Intell Clin Pharm       Date:  1983-10
View more
  4 in total

1.  [Acute compartment syndrome of the forearm after paravasation of contrast medium. Case report].

Authors:  F Ensat; M Babl; M Spies
Journal:  Radiologe       Date:  2010-03       Impact factor: 0.635

2.  [Development of compartment syndrome after intravenous administration of an X-ray contrast medium. Recommendations on acute therapy regimens].

Authors:  N Hawi; M Citak; E Liodakis; M Petri; C Haasper; C Krettek; R Meller
Journal:  Unfallchirurg       Date:  2014-04       Impact factor: 1.000

3.  Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee Guidelines.

Authors:  Giles Roditi; Nadir Khan; Aart J van der Molen; Marie-France Bellin; Michele Bertolotto; Torkel Brismar; Jean-Michel Correas; Ilona A Dekkers; Remy W F Geenen; Gertraud Heinz-Peer; Andreas H Mahnken; Carlo C Quattrocchi; Alexander Radbruch; Peter Reimer; Laura Romanini; Fulvio Stacul; Henrik S Thomsen; Olivier Clément
Journal:  Eur Radiol       Date:  2022-02-17       Impact factor: 7.034

4.  Safety enhancement in adult body computed tomography scanning: comparison of iodixanol versus iohexol.

Authors:  Yong Xiao; Guofei Zeng; Xi Liu; Cong Peng; Changsu Lai; Peihua Zhou
Journal:  Springerplus       Date:  2016-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.